ESAB India Limited (NSE:ESABINDIA)

CTI BioPharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	651.1	383.6	334.4	212	185.7
Short-Term Investments	269.8	86.5	165.1	149.6	1.5
Trading Asset Securities	-	-	-	310.1	410.9
Cash & Short-Term Investments	920.9	470.1	499.5	671.7	598.1
Cash Growth	95.89%	-5.89%	-25.64%	12.31%	-61.03%
Accounts Receivable	2,251	1,888	1,523	1,376	988.2
Other Receivables	6.8	15.4	4.7	4.8	19.8
Receivables	2,258	1,904	1,528	1,381	1,188
Inventory	1,307	1,113	1,234	1,049	734.9
Prepaid Expenses	39.2	34.4	33.4	27	24.5
Other Current Assets	250.5	567.3	217	234	366.2
Total Current Assets	4,775	4,088	3,512	3,363	2,912
Property, Plant & Equipment	1,430	1,277	1,120	919	914.6
Long-Term Investments	6.1	4.4	1.5	1.5	-
Other Intangible Assets	23.3	18.3	26	6.1	6.9
Long-Term Deferred Tax Assets	116.6	19.8	10.8	16.2	14.5
Other Long-Term Assets	119.3	102.1	70.6	55.7	34.2
Total Assets	6,471	5,510	4,740	4,361	3,882
Accounts Payable	1,946	1,334	1,518	1,438	963.9
Accrued Expenses	97	95.2	201.9	224.7	124
Current Portion of Leases	5.6	10.7	5.4	20	14.6
Current Income Taxes Payable	112.3	27	40.2	10.7	0.5
Current Unearned Revenue	-	-	-	21.5	-
Other Current Liabilities	582.6	874.4	270.7	140.2	117.6
Total Current Liabilities	2,743	2,342	2,036	1,855	1,221
Long-Term Leases	33.7	35	34.7	6.8	19.3
Other Long-Term Liabilities	44.7	39.2	43.1	31.5	20.3
Total Liabilities	2,859	2,449	2,137	1,919	1,290
Common Stock	153.9	153.9	153.9	153.9	153.9
Additional Paid-In Capital	93.2	93.2	93.2	93.2	93.2
Retained Earnings	3,355	2,804	2,346	2,185	2,335
Comprehensive Income & Other	10	10	10	10	10
Shareholders' Equity	3,613	3,061	2,603	2,442	2,592
Total Liabilities & Equity	6,471	5,510	4,740	4,361	3,882
Total Debt	39.3	45.7	40.1	26.8	33.9
Net Cash (Debt)	881.6	424.4	459.4	644.9	564.2
Net Cash Growth	107.73%	-7.62%	-28.76%	14.30%	-62.08%
Net Cash Per Share	57.27	27.57	29.84	41.90	36.65
Filing Date Shares Outstanding	15.39	15.39	15.39	15.39	15.39
Total Common Shares Outstanding	15.39	15.39	15.39	15.39	15.39
Working Capital	2,032	1,746	1,475	1,508	1,691
Book Value Per Share	234.68	198.83	169.08	158.66	168.40
Tangible Book Value	3,589	3,042	2,577	2,436	2,585
Tangible Book Value Per Share	233.17	197.64	167.39	158.26	167.95
Land	22.7	22.7	22.7	22.7	22.7
Buildings	530.4	500.6	348.3	335.2	316.8
Machinery	1,613	1,429	1,163	1,069	987.8
Construction In Progress	94.3	42.9	196.1	28.5	25.1

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.